Thallion Pharmaceuticals Inc. is a biotechnology company focussed on developing new treatments for under-served markets in oncology and infectious disease.

Events

November 18, 2009

Poster Presentation at the 2009 AACR-NCI-EORTC Conference

›› more

News

January 11, 2010

Thallion Announces Changes to Executive Management Structure and Board of Directors

December 18, 2009

Thallion Announces Letter of Intent with LFB Biotechnologies to Develop and Commercialize Shigamabs®

December 18, 2009

Thallion Discontinues Phase II Glioblastoma Multiforme Trial After Review of Interim Data

›› archives